WAF1/Cip1, also known as p21, interacts with cdks associated with cyclins A, D1, D2, D3, and E, to inhibit cdk activity. By contrast with other cdk inhibitors such as p16ink4 and p15ink4B, Cip1 only binds to cyclin/cdk complexes. Expression of Cip1 can block cell cycle progression, alter morphology, and induce differentiation. In addition, Cip1 appears to function as a tumor suppressor as its expression causes malignant cells to accumulate at the G0/G1 boundary. The expression of Cip1 is transcriptionally regulated by p53 and its function is critical for p53-dependent G1 arrest following DNA damage.